Skip to main contentAI and Advanced
/
KRSNAA · NSEMarket ticker unavailable · configure an authorised index feed
KR
NSE · Equity shares · Healthcare Facilities6.10 · 1.12%
Krsnaa Diagnostics KRSNAA
NSE:INR 549
BSE:INR 542
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for KRSNAA
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 542.9
Day rangeINR 525 — INR 549
52-week rangeINR 515 — INR 894.4
Volume42,893
Market cap1,749.05
P/E16.62
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)772.77
Net Income (INR Cr)101.43
Rev Growth (5 Year %)14.28
EPS Growth (5 Year %)-12.12
P/E Ratio16.62
Book Value300.74
EPS30.88
Price/BV1.83Computed
Research path: Interpret Krsnaa Diagnostics's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
KRSNAAKrsnaa Diagnostics1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,823.72 | 1,281.6 | 1,171.91 |
| Other Liabilities Total | 69.81 | 23.69 | 22.33 |
| Long Term Debt | 437.14 | 18.5 | 5.5 |
| Common Stock Total | 16.22 | 16.15 | 16.15 |
| Other Current Assets Total | 24.14 | 5.15 | 2.43 |
| Total Assets | 1,823.72 | 1,281.6 | 1,171.91 |
| Current Portof LT Debt/Capital Leases | 66.02 | 17.79 | 22.19 |
| Cash | 30.22 | 3.85 | 2.38 |
| Total Equity | 980.39 | 882.77 | 809.8 |
| Long Term Investments | 93.3 | 129.18 | 15.15 |
| Retained Earnings(Accumulated Deficit) | 964.17 | 206.91 | 132.1 |
| Total Common Shares Outstanding | 3.24 | 3.23 | 3.23 |
| Tangible Book Valueper Share Common Eq | 300.74 | 272.48 | 250.04 |
| Total Liabilities | 843.33 | 398.83 | 362.11 |
| Total Debt | 534.32 | 203.53 | 159.79 |
| Short Term Investments | 361.82 | 64.59 | 172.81 |
| Cashand Short Term Investments | 392.04 | 68.44 | 175.19 |
| Total Receivables Net | 295.51 | 301.49 | 195.4 |
| Deferred Income Tax | 30.02 | 22.59 | 16.43 |
| Accounts Receivable-Trade Net | 295.51 | 281.43 | 187.86 |
| Property/Plant/Equipment Total-Net | 859.7 | 670.4 | 654.57 |
| Total Current Liabilities | 275.2 | 305.39 | 281.47 |
| Total Inventory | 26.66 | 32.67 | 43.55 |
| Accounts Payable | 63.2 | 97.13 | 82.32 |
| Other Currentliabilities Total | 145.98 | 35.57 | 63.94 |
| Total Long Term Debt | 468.29 | 47.16 | 41.88 |
| Intangibles Net | 4.84 | 2.95 | 2.43 |
| Other Long Term Assets Total | 127.53 | 42.45 | 41.2 |
| Total Current Assets | 738.34 | 414.47 | 421.19 |
| Capital Lease Obligations | 31.15 | 28.65 | 36.38 |
| Accumulated Depreciation Total | Not available | -296.16 | -222.97 |
| Accrued Expenses | Not available | 16.32 | 17.3 |
| Prepaid Expenses | Not available | 6.73 | 4.61 |
| Additional Paid-In Capital | Not available | 659.71 | 660.81 |
| Property/Plant/Equipment Total-Gross | Not available | 963.59 | 867.7 |
| Notes Payable/Short Term Debt | Not available | 138.58 | 95.72 |
| Note Receivable-Long Term | Not available | 22.15 | 37.38 |
| Other Equity Total | Not available | Not available | 0.75 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.05
Price to Sale Ratio2.26
Growth
Debt 5Yr CAGR %17.58
Margins
Operating Margin 12m15.72
Operating Margin 5y Avg14.83
Net Profit Margin 12m13.13
Net Profit Margin 5y12
Yield
Dividend Yield %0.36
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk29.47
Analyst consensus
ConsensusStrong Buy
Consensus score1.33
Analyst opinions3
Strong Sell count0
Sell count0
Hold count0
Buy count1
Strong Buy count2
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,907.35 | 1.28 L | 64.93 | — |
| Max Healthcare Institute | INR 1,087.75 | 1.06 L | 71.47 | — |
| Fortis Healthcare | INR 955.05 | 72,031.72 | 67.89 | — |
| Aster DM Healthcare | INR 799.55 | 41,185.67 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,963.75 | 39,975.18 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 27.11%
- FII
- 4.28%
- MF
- 10.17%
- Other
- 58.44%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Krsnaa Diagnostics Ltd Technical Momentum Shifts Amid Bearish Sentiment - MarketsMojoMarket news · 15 Jul 2026, 8:29 am
Krsnaa Diagnostics Ltd Technical Momentum Shifts Amid Bearish Sentiment MarketsMojo
Krsnaa Diagnostics Ltd Technical Momentum Shifts Amid Mixed Market Signals - MarketsMojoMarket news · 14 Jul 2026, 8:06 am
Krsnaa Diagnostics Ltd Technical Momentum Shifts Amid Mixed Market Signals MarketsMojo
Krsnaa Diagnostics Ltd Faces Bearish Momentum Amid Mixed Technical Signals - MarketsMojoMarket news · 14 Jul 2026, 2:32 am
Krsnaa Diagnostics Ltd Faces Bearish Momentum Amid Mixed Technical Signals MarketsMojo
Krsnaa Diagnostics Ltd is Rated Sell by MarketsMOJO - MarketsMojoMarket news · 14 Jul 2026, 2:30 am
Krsnaa Diagnostics Ltd is Rated Sell by MarketsMOJO MarketsMojo
Krsnaa Diagnostics (KRSNAA) Q1 2025 earnings summary - QuartrMarket news · 10 Jul 2026, 10:22 pm
Krsnaa Diagnostics (KRSNAA) Q1 2025 earnings summary Quartr
Krsnaa Diagnostics follows a dual-engine growth strategy - Moneycontrol.comMarket news · 9 Jul 2026, 10:26 am
Krsnaa Diagnostics follows a dual-engine growth strategy Moneycontrol.com
Corporate actions
Events
- annual General MeetingPOM
- dividendRs.2.0000 per share(40%)Final Dividend
- board MeetingsAudited Results & Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.2.7500 per share(55%)Final Dividend
Rusaka Markets Community
Discussion and sentiment for Krsnaa Diagnostics
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Krsnaa Diagnostics Limited is engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation, and tele reporting. The Company’s services include pathology, X-Ray and computed tomography (CT) scans, magnetic resonance imaging (MRI), ultrasonography (USG), tele-radiology, tele-pathology, and other diagnostic services. Its laboratory services span a diverse range of investigations, ranging from CBC or blood glucose to highly specialized tests. Its tele-radiology services enable radiologists to offer treatment remotely. Tele-radiology involves transmitting radiological images, such as CT scans, digitized X-rays, MRIs, and ultrasounds between different locations. It offers Ayaksham package, which includes from basic to total plus health checkups. It provides diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, and others.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- KRSNAA
- BSE Code
- 543328
Questions
Stock FAQ
What is the symbol and ISIN of Krsnaa Diagnostics?
Krsnaa Diagnostics has the symbol KRSNAA and ISIN - INE08LI01020.
What is the current price of Krsnaa Diagnostics?
Krsnaa Diagnostics is currently trading at INR 549.00.
What are the year high and year low of Krsnaa Diagnostics?
Krsnaa Diagnostics has a year high of INR 894.40 and a year low of INR 515.00.
What is the market capitalization of Krsnaa Diagnostics?
Krsnaa Diagnostics has a market capitalization of INR 1,749.05 crore.
What is the P/E ratio of Krsnaa Diagnostics?
Krsnaa Diagnostics has a P/E ratio of 16.62.
What is the dividend yield of Krsnaa Diagnostics?
Krsnaa Diagnostics has a dividend yield of 0.36%.
How is the financial performance of Krsnaa Diagnostics based on revenue, net income, and EPS?
Krsnaa Diagnostics has revenue of INR 772.77 crore, net income of INR 101.43 crore, and EPS of INR 30.86.
What is the book value of Krsnaa Diagnostics?
Krsnaa Diagnostics has a book value of INR 300.74.
What is the debt-to-equity ratio of Krsnaa Diagnostics?
Krsnaa Diagnostics has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Krsnaa Diagnostics?
Krsnaa Diagnostics has a price-to-book ratio of 1.83 and a price-to-sales ratio of 2.26.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.